EMA Withdrawn: Tekturna (aliskiren) — Novartis Europharm Ltd.

View source ↗

Summary

Tekturna (aliskiren) has been withdrawn from the European market by Novartis Europharm Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Status: Withdrawn. Therapeutic area: Hypertension. MAH: Novartis Europharm Ltd.. Decision date: 22/04/2009